Targeting COPZ1 non-oncogene addiction counteracts the viability of thyroid tumor cells

Cancer Lett. 2017 Dec 1:410:201-211. doi: 10.1016/j.canlet.2017.09.024. Epub 2017 Sep 23.

Abstract

Thyroid carcinoma is generally associated with good prognosis, but no effective treatments are currently available for aggressive forms not cured by standard therapy. To find novel therapeutic targets for this tumor type, we had previously performed a siRNA-based functional screening to identify genes essential for sustaining the oncogenic phenotype of thyroid tumor cells, but not required to the same extent for the viability of normal cells (non-oncogene addiction paradigm). Among those, we found the coatomer protein complex ζ1 (COPZ1) gene, which is involved in intracellular traffic, autophagy and lipid homeostasis. In this paper, we investigated the mechanisms through which COPZ1 depletion leads to thyroid tumor cell death. We showed that siRNA-mediated COPZ1 depletion causes abortive autophagy, endoplasmic reticulum stress, unfolded protein response and apoptosis. Interestingly, we observed that mouse tumor xenografts, locally treated with siRNA targeting COPZ1, showed a significant reduction of tumor growth. On the whole, we demonstrated for the first time the crucial role of COPZ1 in the viability of thyroid tumor cells, suggesting that it may be considered an attractive target for novel therapeutic approaches for thyroid cancer.

Keywords: COPZ1; Cell death; Non-oncogene addiction; Thyroid carcinoma.

Publication types

  • Research Support, Non-U.S. Gov't

MeSH terms

  • Animals
  • Apoptosis
  • Autophagy
  • Cell Line, Tumor
  • Cell Survival
  • Coatomer Protein / genetics
  • Coatomer Protein / metabolism*
  • Endoplasmic Reticulum Stress
  • Female
  • Gene Expression Regulation, Neoplastic
  • Humans
  • Mice, Nude
  • RNA Interference
  • RNAi Therapeutics*
  • Signal Transduction
  • Thyroid Neoplasms / genetics
  • Thyroid Neoplasms / metabolism
  • Thyroid Neoplasms / pathology
  • Thyroid Neoplasms / therapy*
  • Time Factors
  • Transfection
  • Tumor Burden
  • Unfolded Protein Response
  • Xenograft Model Antitumor Assays

Substances

  • COPZ1 protein, human
  • Coatomer Protein